Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Market Cap	50.43M
Revenue (ttm)	n/a
Net Income (ttm)	-2.20M
Shares Out	162.68M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	203,954
Average Volume	224,489
Open	0.3350
Previous Close	0.3300
Day's Range	0.3000 - 0.3400
52-Week Range	0.0400 - 0.3600
Beta	0.65
RSI	82.47
Earnings Date	Jul 28, 2025

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Brent Willis
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VM